Capital Research Global Investors Purchases 2,845 Shares of Danaher Corporation $DHR

Capital Research Global Investors grew its position in Danaher Corporation (NYSE:DHR) by 0.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 573,394 shares of the conglomerate’s stock after purchasing an additional 2,845 shares during the period. Capital Research Global Investors’ holdings in Danaher were worth $113,681,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of DHR. WFA of San Diego LLC acquired a new stake in Danaher in the 2nd quarter valued at approximately $26,000. Howard Hughes Medical Institute bought a new stake in Danaher in the 2nd quarter valued at approximately $27,000. ANTIPODES PARTNERS Ltd bought a new stake in Danaher in the 3rd quarter valued at approximately $27,000. TruNorth Capital Management LLC acquired a new position in Danaher during the 3rd quarter worth approximately $28,000. Finally, Tripletail Wealth Management LLC bought a new position in shares of Danaher during the 3rd quarter worth approximately $31,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

DHR has been the topic of a number of recent research reports. Morgan Stanley initiated coverage on shares of Danaher in a report on Monday, December 1st. They issued an “overweight” rating and a $270.00 price objective on the stock. JPMorgan Chase & Co. raised their target price on shares of Danaher from $270.00 to $275.00 and gave the company an “overweight” rating in a research report on Thursday, January 29th. Evercore reiterated an “outperform” rating and issued a $254.00 price target on shares of Danaher in a research note on Wednesday, January 28th. The Goldman Sachs Group cut their price target on shares of Danaher from $270.00 to $265.00 and set a “buy” rating on the stock in a research report on Thursday, January 29th. Finally, Argus set a $265.00 price objective on shares of Danaher in a research note on Wednesday, January 14th. Twenty equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $253.86.

Insiders Place Their Bets

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the sale, the executive vice president owned 5,099 shares in the company, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 11.10% of the company’s stock.

Danaher Trading Down 0.0%

Shares of NYSE:DHR opened at $195.16 on Thursday. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $242.80. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. The company has a market capitalization of $138.00 billion, a P/E ratio of 38.72, a price-to-earnings-growth ratio of 2.64 and a beta of 0.93. The company has a 50-day simple moving average of $220.51 and a 200 day simple moving average of $215.69.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. The firm had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The business’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.14 earnings per share. Sell-side analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, March 27th. This is a boost from Danaher’s previous quarterly dividend of $0.32. Danaher’s payout ratio is presently 25.40%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.